The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Childhood cancer survival in Europe and the United States
Open accessAbstract
BACKGROUND: Survival rates for most major adult cancers are higher in the United States compared with the survival rates in Europe. The objective of this study was to determine whether transatlantic differences in survival also are present in childhood cancers. METHODS: The authors analyzed 16,148 European patients and 3476 patients in the United States who were diagnosed with malignant disease at age < 15 years during 1985–1989. The patients were obtained from 34 EUROCARE cancer registries in 17 countries and from 9 SEER registries in the United States. The authors considered the major 14 diagnostic categories of the International Classification of Childhood Cancers. To increase the power of comparisons, they also considered all childhood cancers together. Observed survival was calculated by actuarial methods. RESULTS: For all cancers combined, northern Europe had the highest 5‐year survival rate at 75% (95% confidence interval [95%CI], 72–78%), and Eastern Europe had the lowest survival rate at 55% (95%CI, 52–58%). The survival rate in the United States was roughly comparable to the survival rates in Italy and other Western European countries at 70%. Northern Europe also had highest survival rate for patients with lymphoid leukemias (83%; 95%CI, 78–88%); whereas Germany, Italy, and the other Western European countries had survival rates similar to the average survival rate for patients in the United States (77%; 95%CI, 74–80%). The survival rate was 7–9% lower in Europe compared with the survival rate in United States for patients with neuroblastoma and Wilms tumors and 8% higher for patients with retinoblastoma (all significant). Small, nonsignificant differences were found for patients with osteosarcoma, ependymoma, and medulloblastoma (with a higher survival rate in the United States) and for patients with acute nonlymphocytic leukemia (with a higher survival rate in Europe). Very similar survival rates among the two populations were found for the other cancers. CONCLUSIONS: Unlike the survival of adults with cancer, the survival of children with cancer in Europe (except Eastern Europe) is very similar to that in the United States. Childhood cancers are generally more responsive to therapy than adult cancers, but these results also may reflect wide accessibility of these treatments for most patients. These results are relevant to the interpretation of differences in adult cancer survival. Cancer 2002;95:1767–72. © 2002 American Cancer Society. DOI 10.1002/cncr.10833
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995
US Department of Health and Human Services; National Cancer Institute (1999) · PsycEXTRA Dataset · doi:10.1037/e407432005-001 · Cited by 1,947
The relative survival rate: a statistical methodology.
Ederer, F., Axtell, L. M., & CUTLER, S. J. (1961) · PubMed · Cited by 1,169
The international incidence of childhood cancer
Parkin, D. M., Stiller, C. A., Draper, G. J., & Bieber, C. A. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420408 · Cited by 1,022
The international classification of childhood cancer
Kramárová, E., & Stiller, C. A. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961211)68:6<759::aid-ijc12>3.0.co;2-w · Cited by 534
A computer program package for relative survival analysis
Hakulinen, T., & Abeywickrama, K. H. (1985) · Computer Programs in Biomedicine · doi:10.1016/0010-468x(85)90011-x · Cited by 344
Toward a comparison of survival in American and European cancer patients
Gatta, G., Capocaccia, R., Coleman, M. P., Gloeckler Ries, L. A., Hakulinen, T., Micheli, A., Sant, M., Verdecchia, A., & Berrino, F. (2000) · Cancer · doi:10.1002/1097-0142(20000815)89:4<893::aid-cncr24>3.0.co;2-9 · Cited by 337
Self-citationSurvival of Cancer Patients in Europe: The EUROCARE-2 study.
etc. (1999) · PubMed · Cited by 164
U.S. childhood cancer survival, 1973–1987
Novakovic, B. (1994) · Medical and Pediatric Oncology · doi:10.1002/mpo.2950230606 · Cited by 72
Cited by
Mirabello, L., Troisi, R. J., & Savage, S. A. (2009) · Cancer · doi:10.1002/cncr.24121 · Cited by 2,199
The Epidemiology of Osteosarcoma
Ottaviani, G., & Jaffe, N. (2009) · Cancer Treatment and Research · doi:10.1007/978-1-4419-0284-9_1 · Cited by 1,786
Cancer survival in five continents: a worldwide population-based study (CONCORD)
Coleman, M. P., Quaresma, M., Berrino, F., Lutz, J.-M., De Angelis, R., Capocaccia, R., Baili, P., Rachet, B., Gatta, G., Hakulinen, T., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70179-7 · Cited by 1,002
Self-citationMirabello, L., Troisi, R. J., & Savage, S. A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24320 · Cited by 791
Šimůnek, T., Štěrba, M., Popelová, O., Adamcová, M., Hrdina, R., & Geršl, V. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70018-0 · Cited by 769
EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century
Coleman, M. P., Gatta, G., Verdecchia, A., Estève, J., Sant, M., Storm, H., Allemani, C., Ciccolallo, L., Santaquilani, M., & Berrino, F. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg756 · Cited by 483
Self-citationChemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?
Anninga, J. K., Gelderblom, H., Fiocco, M., Kroep, J. R., Taminiau, A. H. M., Hogendoorn, P. C. W., & Egeler, R. M. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.05.030 · Cited by 456
Murphy, E., Ardehali, H., Balaban, R. S., DiLisa, F., Dorn, G. W., Kitsis, R. N., Otsu, K., Ping, P., Rizzuto, R., Sack, M. N., et al. (2016) · Circulation Research · doi:10.1161/res.0000000000000104 · Cited by 458
Wouters, K. A., Kremer, L. C. M., Miller, T. L., Herman, E. H., & Lipshultz, S. E. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05759.x · Cited by 453
Childhood Cancer Survival Trends in Europe: A EUROCARE Working Group Study
Gatta, G., Capocaccia, R., Stiller, C., Kaatsch, P., Berrino, F., Terenziani, M., & the EUROCARE Working Group (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.554 · Cited by 315
Self-citationPeriod analysis for ‘up-to-date’ cancer survival data
Brenner, H., Gefeller, O., & Hakulinen, T. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.10.013 · Cited by 309
Using Epidemiology and Genomics to Understand Osteosarcoma Etiology
Savage, S. A., & Mirabello, L. (2011) · Sarcoma · doi:10.1155/2011/548151 · Cited by 303
van Dalen, E. C., van der Pal, H. J. H., Kok, W. E. M., Caron, H. N., & Kremer, L. C. M. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.08.005 · Cited by 284
Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency
Visser, J. A., Schipper, I., Laven, J. S. E., & Themmen, A. P. N. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.224 · Cited by 264
Protective Effects of Spironolactone Against Anthracycline-Induced Cardiomyopathy
Akpek, M., Ozdogru, I., Sahin, O., Inanc, M., Dogan, A., Yazici, C., Berk, V., Karaca, H., Kalay, N., Oguzhan, A., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.196 · Cited by 258
New policies to address the global burden of childhood cancers
Sullivan, R., Kowalczyk, J. R., Agarwal, B., Ladenstein, R., Fitzgerald, E., Barr, R., Steliarova-Foucher, E., Magrath, I., Howard, S. C., Kruger, M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70007-x · Cited by 121
Quality of systematic reviews in pediatric oncology – A systematic review
Lundh, A., Knijnenburg, S. L., Jørgensen, A. W., van Dalen, E. C., & Kremer, L. C. M. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.08.010 · Cited by 78
Care of a Child Dying of Cancer: The Role of the Palliative Care Team in Pediatric Oncology
Postovsky, S., & Arush, M. W. B. (2004) · Pediatric Hematology and Oncology · doi:10.1080/08880010490264037 · Cited by 39
Metadata
- Authors
- Gatta, G., Capocaccia, R., Coleman, M. P., Ries, L. A. G., & Berrino, F.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2002-10-03
- Volume
- 95
- Issue
- 8
- Pages
- 1767-1772
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2059341564
- Cited by
- 258
- References
- 8
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.